Ashwagandha for Sleep: What the Trials Measured, How Long It Takes, Who It Suits

TL;DR
- Ashwagandha (Withania somnifera) is a root used in Ayurvedic practice for centuries, now studied for stress and sleep.
- Three randomized placebo-controlled trials and a meta-analysis of five trials have measured sleep outcomes. The pooled effect is small to moderate and clearest in adults with diagnosed insomnia, at 600 mg a day or more, for eight weeks or longer.
- It is slow-acting. Trials ran six to ten weeks. A single capsule before bed is not how it was studied.
- The trials used extracts standardised for withanolides, 120 to 600 mg a day. Several were industry-funded.
- It is a botanical, so its EU health claims are on hold. The framing here is traditional use plus what the trials measured.
Ashwagandha has moved from Ayurvedic pharmacies to the front shelf of every supplement shop, usually pitched at stress and sleep, and usually talked about like a fast fix. That is the first thing to correct. It is a slow-burn herb, and knowing that changes how you'd use it and what to expect.
What ashwagandha is
Ashwagandha is a small shrub whose root has been used in Ayurvedic medicine across South Asia for well over two thousand years. In that tradition it is classed as an adaptogen, a group of herbs taken to help the body cope with stress. The name translates roughly as "smell of horse", a nod to the earthy root and the vigour it was associated with. The compounds behind the modern research interest are withanolides, a family of steroidal lactones concentrated in the root.
How researchers think it works
The mechanism that has drawn the most study is ashwagandha's effect on the hypothalamic-pituitary-adrenal axis, the system that governs cortisol. Cortisol follows a daily rhythm, high in the morning and low at night, and chronic stress disturbs that rhythm. Some withanolides also show activity at GABA-A receptors in laboratory studies. These are mechanisms under investigation, and they are the reason ashwagandha gets studied in the context of stress and sleep rather than evidence that it works through them in people. The stress and sleep link itself is covered in cortisol and sleep.
What the trials measured
Three randomized, double-blind, placebo-controlled trials carry most of the weight.
In a 2019 trial at a hospital in India, 60 patients with insomnia and anxiety took 300 mg of a full-spectrum ashwagandha root extract twice daily, or placebo, for ten weeks, with sleep measured by actigraphy. Sleep onset latency improved in both groups by week five and ten. At ten weeks it was shorter on ashwagandha, 29.0 minutes against 33.9 on placebo (p = 0.019). Sleep efficiency rose from 75.6 to 83.5 percent on ashwagandha and from 75.1 to 79.7 on placebo. Sleep quality scores and anxiety scores also changed against placebo (Langade 2019). Forty people took the extract and twenty took placebo, and the group is small.
A 2020 trial gave 150 healthy adults with non-restorative sleep 120 mg of a different standardised extract once daily, or placebo, for six weeks. Self-reported sleep quality rose 72 percent in the treatment group against 29 percent on placebo. On actigraphy, sleep efficiency, total sleep time, sleep latency and wake after sleep onset all moved against placebo. No treatment-related adverse events were reported (Deshpande 2020).
A 2021 meta-analysis pooled five randomized trials with 400 participants. Ashwagandha extract showed a small to moderate effect on overall sleep, a standardized mean difference of -0.59, with substantial heterogeneity between trials. The effect was more prominent in adults diagnosed with insomnia, at doses of 600 mg a day or more, and with treatment of eight weeks or longer. The authors noted that data on serious adverse effects are limited and that long-term safety is unknown (Cheah 2021).
Ashwagandha has more randomized trial data than most botanicals sold for sleep, which counts in its favour. The trials are relatively small, several are funded by the companies that make the extracts, and the extracts differ between studies. The honest read is real but still developing evidence, worth neither dismissing nor overselling.
It works slowly, if it works
The single most useful thing to know is that the studies did not measure overnight effects. The trials ran six to ten weeks, and the meta-analysis found the effect clearest at eight weeks or longer (Cheah 2021). If you try it and nothing happens in the first week, that matches the research pattern. This is a compound built around consistency over weeks.
Forms and dose
The trials used extracts standardised for withanolide content, sold under names such as KSM-66, Sensoril and Shoden. Doses ran from 120 mg a day of a concentrated extract (Deshpande 2020) to 600 mg a day (Langade 2019), and the pooled signal was strongest at 600 mg or more (Cheah 2021). The label matters here. An unstandardised root powder does not match what was studied.
Studies dosed in the morning, in the evening or twice daily, and the common thread is daily use over weeks rather than a particular time of night.
Who it tends to suit
The research centres on the stress-hormone system, and the clearest signal in the meta-analysis was in people with diagnosed insomnia. If your nights are broken because your mind won't switch off from the day, that is closest to the populations the trials recruited. For sleep problems with a physical driver, the evidence points elsewhere. For how ashwagandha sits next to other options, see natural sleep supplements.
What to watch
Ashwagandha was well tolerated in the trials, with mild digestive upset the most reported complaint. It is not recommended in pregnancy. People with thyroid conditions, or on sedative or immune-modulating medication, should check with a professional first, since it can interact. Anyone with a liver condition should be cautious, as rare cases of liver problems have been reported with ashwagandha products. The meta-analysis authors flagged that long-term safety data are limited (Cheah 2021).
Frequently asked questions
Does ashwagandha help you sleep?
In the pooled trials it had a small to moderate effect on sleep measures, clearest in adults with diagnosed insomnia, at 600 mg a day or more, over eight weeks or longer (Cheah 2021). The trials are small and several are industry-funded. Its EU claims are on hold.
How long does ashwagandha take to work?
The trials ran six to ten weeks before measuring. It was not tested as a single-dose sleep aid.
What dose and form did the research use?
Standardised extracts, 120 to 600 mg a day, with the pooled effect strongest at 600 mg or more. Look for a product standardised for withanolides.
When should I take it?
The trials used morning, evening and twice-daily dosing. Daily consistency over weeks mattered more than the hour.
Who should not take ashwagandha?
It is not recommended in pregnancy. People with thyroid or liver conditions, or on sedative or immune-modulating medication, should check with a professional first.
Disclaimer
This article is for general information only. It is not medical advice and it does not replace guidance from a qualified healthcare professional. Ashwagandha can interact with thyroid, sedative and immune-modulating medication and is not recommended in pregnancy. Food supplements are not a substitute for a varied diet and a healthy lifestyle. Do not use this information to diagnose or treat any condition. Speak with your doctor before starting any supplement.
Sources
- Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus. 2019;11(9):e5797. https://pubmed.ncbi.nlm.nih.gov/31728244/
- Deshpande A, Irani N, Balkrishnan R, Benny IR. A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha (Withania somnifera) extract on sleep quality in healthy adults. Sleep Med. 2020;72:28-36. https://pubmed.ncbi.nlm.nih.gov/32540634/
- Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R. Effect of ashwagandha (Withania somnifera) extract on sleep: a systematic review and meta-analysis. PLoS One. 2021;16(9):e0257843. https://pubmed.ncbi.nlm.nih.gov/34559859/
About the Author

Nima Koucheki
Founder, Sleep Improvers
Nima Koucheki is the founder of Sleep Improvers. He hosts a podcast and YouTube channel dedicated to sleep science, translating peer-reviewed research into protocols anyone can apply tonight.